Minocycline in Stroke Study at Maimonides
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1164 participants.
Also called NCT07237048
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 1,164 participants
- Sponsor
- Joyce Chen
- Registry
-
NCT07237048
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07237048. Randomized; single masking; primary purpose treatment. Start 2026-02-02 (actual); primary completion 2028-12-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Minocycline in Stroke Study at Maimonides
- Condition
- Stroke
- Condition
- Ischemia Stroke
- Condition
- Hemorrhagic Strokes
- Condition
- Mortality
- Condition
- Morbidity
- Condition
- Cerebrovascular Accident (Stroke)
- Condition
- Intracerebral Haemorrhage (ICH)
- Intervention (Drug)
- Minocycline 200mg
- Lead sponsor
- Joyce Chen
Record details
- Record id
cardio:ct-nct07237048- Content hash
1619687a7ba7b00a688a88fa0a602ca89e90e6022d75ba0497168c3fd6ffb484